PRESS RELEASE: Dr. Patricia Deverka Appointed as IVI's First Chief Science Officer

The Innovation and Value Initiative (IVI) appoints Patricia Deverka, MD, as its first Chief Science Officer.

ALEXANDRIA, Va., February 4, 2020 — The Innovation and Value Initiative (IVI), whose mission is to strengthen value assessment in healthcare that reflects its five principles of scientific rigor, transparency, patient centricity, innovation and market-based solutions, today announced that Patricia Deverka, MD, has joined the non-profit as its first Chief Science Officer. With close to 30 years of experience in the fields of health economics and outcomes research, health policy, stakeholder engagement and business development for corporations and non-profits alike, Dr. Deverka joins IVI from Geisinger National Precision Health, where she was the director for value evidence and outcomes. She is also a member of the National Human Genome Research Institute and National Advisory Council and has published on topics ranging from innovative technologies to patient engagement.

“We are excited to welcome Dr. Deverka to our team,” said Jennifer Bright, IVI’s executive director. “Her varied experience in health economics research, especially her work to meaningfully incorporate patient perspectives into clinical studies, are exactly the credentials that are needed to make a difference in the world of value assessment.”

For more on Dr. Deverka’s appointment, you can read the full press release.

Related Videos
Dr Ajay Goel
Dr Ajay Goel
Julie Patterson, PharmD, PhD
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Screenshot of Fran Gregory, PharmD, MBA, during a video interview
Yael Mauer, MD, MPH
Pregnant Patient | image credit: pressmaster -
Dr Julie Patterson, National Pharmaceutical Council
Diana Isaacs, PharmD
Beau Raymond, MD
Related Content
CH LogoCenter for Biosimilars Logo